Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anil H. Shyam Mohan"'
Publikováno v:
Journal of Genetic Engineering and Biotechnology, Vol 20, Iss 1, Pp 1-14 (2022)
Highlights The physicochemical properties of putrescine monooxygenase from Shewanella putrefaciens-95 were compared with other known N-hydroxylating monooxygenases. The phylogenetic analysis of SpPMO and other selected class B monooxygenases clearly
Externí odkaz:
https://doaj.org/article/a5b90121436b4437ad5751fadb428647
Publikováno v:
Journal of Applied Biology & Biotechnology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::669562ba397fa11a9f4aa3a1772f676d
https://doi.org/10.7324/jabb.2023.111162
https://doi.org/10.7324/jabb.2023.111162
Publikováno v:
Journal, genetic engineeringbiotechnology. 20(1)
The enormous and irresponsible use of antibiotics has led to the emergence of resistant strains of bacteria globally. A new approach to combat this crisis has been nutritional immunity limiting the availability of nutrients to pathogens. Targeting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d60695021f6945f074166fae3e1fe9f
https://pubmed.ncbi.nlm.nih.gov/35412199
https://pubmed.ncbi.nlm.nih.gov/35412199
Publikováno v:
Protein Expression and Purification. 157:9-16
A putrescine monooxygenase from Shewanella putrefaciens 95 (SpPMO) is the initial enzyme catalyzing the hydroxylation of putrescine to N-hydroxyl putrescine, the precursor for the synthesis of a siderophore putrebactin was identified. This PMO cluste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0edccee64bba8d850a43a19f4640693
https://doi.org/10.1016/j.pep.2019.01.006
https://doi.org/10.1016/j.pep.2019.01.006
Autor:
Suma Sreenivas, Kedarnath Nanjund Sastry, Sateesh M. Krishnaiah, Amarnath Chatterjee, Anil H. Shyam Mohan, Nagaraja Govindappa, Niveditha Mallikarjun
Publikováno v:
Protein Expression and Purification. 118:1-9
Insulin glargine is a slow acting analog of insulin used in diabetes therapy. It is produced by recombinant DNA technology in different hosts namely E. coli and Pichia pastoris. In our previous study, we have described the secretion of fully folded t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3e3e11ebacbb84a6e20c247821af400
https://doi.org/10.1016/j.pep.2015.10.002
https://doi.org/10.1016/j.pep.2015.10.002
Publikováno v:
Protein Expression and Purification. 167:105546
The presence of antibiotic resistance genes in genetically modified bacteria raises a regulatory concern in the production of therapeutic proteins and additionally reduces the number of plasmids available for propagation in a cell. Cre recombinase fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7065ab57ee633ebe4ac92475f99b19d2
https://doi.org/10.1016/j.pep.2019.105546
https://doi.org/10.1016/j.pep.2019.105546